SOL GEL TECHNOLOGIES
SLGL·M8694L137·US·Common Stock·Healthcare - Biotechnology-Activist
SLGL (SOL GEL TECHNOLOGIES) is held by 13 institutional investors as of Q1 2026. Largest holders: Phoenix Financial Ltd. ($16.7M), CITADEL ADVISORS LLC ($2.9M), XTX Topco Ltd ($634,552). Net institutional sentiment: Mixed.
13
Holders
Avg rating(2 Elite)
$22.7M
Total Value
58% (15)
Fund Consensus
7 buying - 5 selling
Who's Trading
InsiderOIOpaleye Management Inc.Buy $17KJul 10, 2026
InsiderOIOpaleye Management Inc.Buy $22KJul 8, 2026
InsiderOIOpaleye Management Inc.Buy $130KMay 13, 2026
InsiderOIOpaleye Management Inc.Buy $102KMay 12, 2026
ActivistOPOpaleye Management Inc.15.4%May 6, 2026
ActivistMAMoshe Arkin56.6%Apr 15, 2026
ActivistGPGreat Point Partners, LLC8.4%Mar 31, 2026
InsiderOIOpaleye Management Inc.Buy $2.5MMar 24, 2026
InsiderOIOpaleye Management Inc.Buy $360KMar 24, 2026
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer